Summary
- Profile Type
- Technology offer
- POD Reference
- TOTR20240327016
- Term of Validity
- 27 March 2024 - 27 March 2025
- Company's Country
- Turkey
- Type of partnership
- Commercial agreement with technical assistance
- Targeted Countries
- ItalyFranceGermanyBelgiumPolandSwitzerlandDenmarkSwedenNorwayUnited KingdomGreeceBulgariaLuxembourgAustriaNetherlandsSpain
Contact the EEN partner nearest to you for more information.
Find my local partner
General information
- Short Summary
- Turkish researchers are seeking to transfer the patent for magnetically targeted and in vivo proven effective nanoantibiotic for the treatment of osteomyelitis in the medical sector, or to find a manufacturing company. This system is available for patent transfer or partnership with a manufacturer.
- Full Description
-
The invention is a targeted drug delivery system for treating osteomyelitis. It uses gentamicin loaded and gelatin coated magnetite nanoparticles. This system reduces drug toxicity and resistance by delivering antibiotics directly to the infected area. The nanoparticles are biodegradable and are directed to the infection site using an external magnetic field. In vivo studies have shown promising results in animal models.
The inventors are in search of a company that can acquire the patent rights to their product. Additionally, the inventors intend to secure partnering and licensing agreements globally and across the various health and wellness sectors. The company will work with route-to-market partners to adapt the process to optimize the efficacy of prototype. - Advantages and Innovations
- By developing biodegradable and magnetic targeted antibiotics delivery system for treating osteomyelitis, drug resistance and toxicity are reduced, and besides this, therapeutic efficiency is increased. The inventors have deep know-how and a filed patent for nanoantibiotic in osteomyelitis.
- Stage of Development
- Lab tested
- Sustainable Development Goals
- Goal 9: Industry, Innovation and InfrastructureGoal 3: Good Health and Well-beingGoal 12: Responsible Consumption and Production
Partner Sought
- Expected Role of a Partner
-
Partnership through a commercial agreement with technical assistance, including licensing opportunities is sought. The ideal partner is a company that want to take over the patent.
The Turkish inventors are open to collaborate under licensed manufacturing and marketing of the prototype. - Type and Size of Partner
- Big company
- Type of partnership
- Commercial agreement with technical assistance
Call details
- Coordinator required
-
Yes
Dissemination
- Technology keywords
- 06001015 - Pharmaceutical Products / Drugs
- Market keywords
- 05007002 - Pharmaceuticals/fine chemicals
- Targeted countries
- ItalyFranceGermanyBelgiumPolandSwitzerlandDenmarkSwedenNorwayUnited KingdomGreeceBulgariaLuxembourgAustriaNetherlandsSpain